Menalled, L.B. and Patry, M. and Ragland, N. and Lowden, Philip A.S. and Goodman, J. and Minnich, J. and Zahasky, B. and Park, L. and Leeds, J. and Howland, D. and Signer, E. and Tobin, A.J. and Brunner, D. (2010) Comprehensive behavioral testing in the R6/2 mouse model of Huntington's disease shows no benefit from CoQ10 or minocycline. PLoS One 5 (3), ISSN 1932-6203.
1027.pdf - Published Version
Available under License Creative Commons Attribution.
Download (1296Kb) | Preview
Previous studies of the effects of coenzyme Q10 and minocycline on mouse models of Huntington’s disease have produced conflicting results regarding their efficacy in behavioral tests. Using our recently published best practices for husbandry and testing for mouse models of Huntington’s disease, we report that neither coenzyme Q10 nor minocycline had significant beneficial effects on measures of motor function, general health (open field, rotarod, grip strength, rearing-climbing, body weight and survival) in the R6/2 mouse model. The higher doses of minocycline, on the contrary, reduced survival. We were thus unable to confirm the previously reported benefits for these two drugs, and we discuss potential reasons for these discrepancies, such as the effects of husbandry and nutrition.
|School or Research Centre:||Birkbeck Schools and Research Centres > School of Science > Biological Sciences|
|Date Deposited:||04 Aug 2010 14:09|
|Last Modified:||17 Apr 2013 12:33|
Archive Staff Only (login required)